<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141382">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02095483</url>
  </required_header>
  <id_info>
    <org_study_id>27425</org_study_id>
    <nct_id>NCT02095483</nct_id>
  </id_info>
  <brief_title>Brain Connectivity and Mindfulness Training in Youth With Bipolar Disorder-Not Otherwise Specified</brief_title>
  <official_title>Brain Connectivity and Mindfulness Training in Youth With Bipolar Disorder NOS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study seeks to test the effectiveness of mindfulness based therapy on neural network in
      youth at high risk for developing bipolar disorder. TO do this, the investigators propose to
      conduct a brain scan in adolescents before and after participation in a 12 week mindfulness
      based stress reduction program. The investigators will also assess behavioral outcome
      measures before and after completing the mindfulness based therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Children's Depression Rating Scale</measure>
    <time_frame>change from baseline after 12 weeks of therapy</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>depression rating within 2 week time frame</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Children's Affective Lability Scale</measure>
    <time_frame>change from baseline after 12 weeks of thera</time_frame>
    <safety_issue>No</safety_issue>
    <description>measures degree of mood lability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Young Mania Rating Scale</measure>
    <time_frame>change from baseline after 12 weeks of thera</time_frame>
    <safety_issue>No</safety_issue>
    <description>measures mania rating within 1 week time frame</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Mindfulness Group Therapy (12 week)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness Group Therapy Study</intervention_name>
    <arm_group_label>Mindfulness Group Therapy (12 week)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 13-18, diagnosed with bipolar disorder-not otherwise specified, first or second
             degree relative diagnosed with bipolar I or II.

        Exclusion Criteria:

          -  Not English speaking. For those who are to participate int he scan, having any metal
             in the body or movement disorders will be an exclusionary factor
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>13 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kiki Chang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paige J Staudenmaier, BA</last_name>
    <phone>650-725-6760</phone>
    <email>pstaudenmaier@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford Behavioral Sciences and Psychiatry</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paige Staudenmaier, BA</last_name>
      <phone>650-725-6760</phone>
      <email>pstaudenmaier@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Kiki Chang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 20, 2014</lastchanged_date>
  <firstreceived_date>March 19, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
